- 29 Jul 2017 Allan Bradley at Canaccord Genuity Growth Conference
- 9 Jan 2017 Kymab expands Infectious Disease Programmes
- 24 Nov 2016 Kymab secures US$100 million Series C funding
- 6 May 2015 Kymab secures US$90 million funding
- 16 May 2014 Gates and Wellcome Trust invest in Kymab
- 12 Jul 2010 Wellcome Trust £20 million financing agreement
We use cookies on our website. Carry on browsing if you’re happy with this or find out more
Featured article: Forbes on Kymab: exciting the big guys
Forbes magazine recognises Kymab's work is 'exciting the big and little guys' and places the company in a select group of UK 'Unicorns'
Read article
Featured article: Promising First Clinical Study of KY1005 for immune-mediated diseases
Positive data in Phase I trial of KY1005 will lead to Phase II studies in atopic dermatitis, with additional plans to run studies in othe...
Read article